Effects of High-Dose Intravenous Vitamin C on Colorectal Cancer Recurrence: The Retrospective Study by Medical Records for 23 Years
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Among the complementary and alternative therapies used to treat cancer, studies have reported since the late 1960s that the intravenous administration of high-dose vitamin C had an anticancer effect. As the incidence of colorectal cancer has recently increased, interest in treating and preventing its recurrence has also increased. Therefore, this study investigated whether the intravenous administration of high-dose vitamin C to patients with colorectal cancer who received chemotherapy after radical resection would reduce recurrence rates.Methods: One hundred eighty patients who were diagnosed with colorectal cancer and received chemotherapy after surgery at a university hospital in Busan for a total of 23 years from January 2000 to March 2023 were retrospectively studied. Of them, 30 were administered high-dose (1 g/kg) intravenous vitamin C injections twice weekly for more than 5 weeks in addition to standard treatments, while the remaining 150 patients who received only standard treatments were assigned to the control group. In both groups, a thorough examination was performed every year after surgery. The chi-squared test was performed to compare 5-year recurrence rates.Results: The control group had higher recurrence and mortality rates than the experimental group; however, the differences were not statistically significant. The recurrence rate was 28.1% in the stage 2 and 3 control groups, non-significantly higher than that in the experimental group (18.8%; P>0.05).Conclusions: There was no statistically significant difference in recurrence among patients with colorectal cancer who received chemotherapy, although the 5-year recurrence rate was decreased in the experimental versus control group.
Abstract
Background: Among the complementary and alternative therapies used to treat cancer, studies have reported since the late 1960s that the intravenous administration of high-dose vitamin C had an anticancer effect. As the incidence of colorectal cancer has recently increased, interest in treating and preventing its recurrence has also increased. Therefore, this study investigated whether the intravenous administration of high-dose vitamin C to patients with colorectal cancer who received chemotherapy after radical resection would reduce recurrence rates.Methods: One hundred eighty patients who were diagnosed with colorectal cancer and received chemotherapy after surgery at a university hospital in Busan for a total of 23 years from January 2000 to March 2023 were retrospectively studied. Of them, 30 were administered high-dose (1 g/kg) intravenous vitamin C injections twice weekly for more than 5 weeks in addition to standard treatments, while the remaining 150 patients who received only standard treatments were assigned to the control group. In both groups, a thorough examination was performed every year after surgery. The chi-squared test was performed to compare 5-year recurrence rates.Results: The control group had higher recurrence and mortality rates than the experimental group; however, the differences were not statistically significant. The recurrence rate was 28.1% in the stage 2 and 3 control groups, non-significantly higher than that in the experimental group (18.8%; P>0.05).Conclusions: There was no statistically significant difference in recurrence among patients with colorectal cancer who received chemotherapy, although the 5-year recurrence rate was decreased in the experimental versus control group.
참고문헌 (24)
- "Thematic statistics. Health, Social and Welfare" (2023)[URL]
- "The cancer that I want to know. Colon cancer" (2023)[URL]
- Benade L, "Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1, 2, 4, -triazole", Oncology, 23(1), pp.33~43 (1969)
- Cameron E, "Supplemental ascorbate in the supportive treatment of cancer : prolongation of survival times in terminal human cancer", Proc Natl Acad Sci U S A, 73(10), pp.3685~3689 (1976)
- Riordan HD, "Intravenous vitamin C as a chemotherapy agent : a report on clinical cases", P R Health Sci J, 23(2), pp.115~118 (2004)
- Chen J, "High-dose vitamin C tends to kill colorectal cancer with high MALAT1 expression", J Oncol, 2020, pp.2621308~ (2020)
- Yun J, "Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH", Science, 350(6266), pp.1391~1396 (2015)
- Wang F, "A randomized, open-label, multicenter, phase 3 study of high-dose vitamin C plus FOLFOX ± Bevacizumab versus FOLFOX ± bevacizumab in unresectable untreated metastatic colorectal cancer(vitality study)", Clin Cancer Res, 28(19), pp.4232~4239 (2022)
- Pawlowska E, "Pro-and antioxidant effects of vitamin C in cancer in correspondence to Its dietary and pharmacological concentrations", Oxid Med Cell Longev, 2019, pp.7286737~ (2019)
- Benson AB 3rd, "American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer", J Clin Oncol, 22(16), pp.3408~3419 (2004)
- Carlsson U, "Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy", Dis Colon Rectum, 30(6), pp.431~434 (1987)
- Galandiuk S, "Patterns of recurrence after curative resection of carcinoma of the colon and rectum", Surg Gynecol Obstet, 174(1), pp.27~32 (1992)
- Stipa S, "Local recurrence after curative resection for colorectal cancer : frequency, risk factors and treatment", J Surg Oncol Suppl, 2, pp.155~160 (1991)
- Kim YM, "The analysis of risk factors for overall survival after recurrence in recurred colorectal carcinoma", Korean J Clin Oncol, 10(2), pp.97~102 (2014)
- Pilipshen SJ, "Patterns of pelvic recurrence following definitive resections of rectal cancer", Cancer, 53(6), pp.1354~1362 (1984)
- Malcolm AW, "Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum", Surg Gynecol Obstet, 152(2), pp.131~136 (1981)
- Adloff M, "Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum", Dis Colon Rectum, 28(6), pp.413~415 (1985)
- Polk HC Jr, "Recurrent colorectal carcinoma : detection, treatment, and other considerations", Surgery, 69(1), pp.9~23 (1971)
- Park IJ, "Pattern of recurrences and metastases after a curative resection for primary colorectal cancer", J Korean Soc Coloproctol, 24(3), pp.207~213 (2008)
- Longo DL, "Harrison’s principles of internal medicine", pp.749~ (2013), McGraw Hill
- Cameron E, "Supplemental ascorbate in the supportive treatment of cancer : reevaluation of prolongation of survival times in terminal human cancer", Proc Natl Acad Sci U S A, 75(9), pp.4538~4542 (1978)
- Moertel CG, "High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison", N Engl J Med, 312(3), pp.137~141 (1985)
- Levine M, "Vitamin C pharmacokinetics in healthy volunteers : evidence for a recommended dietary allowance", Proc Natl Acad Sci U S A, 93(8), pp.3704~3709 (1996)
- Graumlich JF, "Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion", Pharm Res, 14(9), pp.1133~1139 (1997)